KN026 (anti-HER2 bispecific antibody) in patients with previously treated, advanced HER2-expressing gastric or gastroesophageal junction cancerJianming Xu, Qian Wang, Yanqiao Zhang et al.|European Journal of Cancer|2022Cited by 54
The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression.Jianming Xu, Ting Xu, Yun Zhang et al.|Journal of Clinical Oncology|2021Cited by 13
A phase II study evaluating KN026 monotherapy in patients (pts) with previously treated, advanced HER2-expressing gastric or gastroesophageal junction cancers (GC/GEJC).Jianming Xu, Qian Wang, Rongrui Liu et al.|Journal of Clinical Oncology|2022Cited by 6